Restless Legs Syndrome Clinical Trial
Official title:
Sifrol® (Pramipexole) Impact on RLS Related Quality of Life: A 12-weeks Observational Study in Patients With Primary RLS
In this German non-interventional observational study 1980 patients diagnosed with Restless
Legs Syndrome (RLS) will be investigated by 990 General Practitioners across all federal
states in Germany. Both moderate to severe RLS patients, with or without previous RLS
treatment, suffering from RLS symptoms like a desire to move the extremities usually
associated with some discomfort, motor restlessness and worsening of symptoms at rest with
at least temporary relief by activity, worsening of symptoms later in the day or at night,
are eligible for this study, if it is planned to initiate therapy with pramipexole or to add
pramipexole to a previously given, insufficient therapy. Three visits are planned to be
documented in this PMS study, one baseline visit, visit two after the end of pramipexole
titration and visit three after 12 weeks of treatment. Evaluations and visits are to be
carried out and documented only if part of routine medical practice. The main goal of
observational studies is to determine how pramipexole treatment works when applied in actual
practice and thus maximise external validity. In actual practice patients who have been
excluded in the clinical registration trials of PPX in moderate to severe primary RLS (i.e.
those with certain disease histories, co-morbidities and/or demographic characteristics)
will be treated with PPX. Thus in addition during this observational study information on
the efficacy and safety of PPX in those patients will be obtained. The objectives of this
PMS study are:
- To evaluate the treatment effect of pramipexole on RLS severity and general improvement
as measured by IRLS and CGI-I.
- To evaluate quality of life of RLS patients as measured by the Restless Legs Syndrome
Quality of Life questionnaire (RLS-QoL).
- To evaluate the safety profile of PPX in a natural study population.
n/a
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04786314 -
The Effect of Hot and Cold Water Application on Pregnant Women With Restless Leg Syndrome
|
N/A | |
| Completed |
NCT01455012 -
Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome
|
Phase 4 | |
| Terminated |
NCT01192503 -
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
|
Phase 2/Phase 3 | |
| Completed |
NCT00721279 -
Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs Syndrome
|
N/A | |
| Completed |
NCT00530530 -
ASP8825 - Study in Patients With Restless Legs Syndrome
|
Phase 2 | |
| Completed |
NCT00375284 -
A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS
|
Phase 4 | |
| Completed |
NCT00942253 -
Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS)
|
Phase 2 | |
| Completed |
NCT00479531 -
Sequential Compression Devices for Treatment of Restless Legs Syndrome
|
Phase 3 | |
| Recruiting |
NCT05581576 -
Pitolisant in Refractory Restless Legs Syndrome
|
Phase 4 | |
| Active, not recruiting |
NCT03218969 -
Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04144790 -
Impact of Iron Supplementation Treatment on Brain Iron Concentrations
|
||
| Completed |
NCT05787080 -
Massage, Oxidative and Antioxidant Enzymes in Hemodialysis Patients With Restless Legs Syndrome(RLS)
|
N/A | |
| Not yet recruiting |
NCT05529095 -
Sublingual Apomorphine in Refractory Restless Legs Syndrome
|
Phase 4 | |
| Recruiting |
NCT05044520 -
Clinical Features Associated With Restless Legs Syndrome.
|
||
| Withdrawn |
NCT03849001 -
Impact of Acute Leg Cycling at Various Intensities on RLS Severity in Persons With MS
|
N/A | |
| Completed |
NCT03076541 -
Cardiovascular Variability, Heart Rate Response, and Electromyogram Power Associated With Periodic Leg Movements.
|
N/A | |
| Recruiting |
NCT04145674 -
A Proof of Concept, Phase 2, Double-blind, Randomized Trial With d-Methadone Product Versus Placebo
|
Phase 2 | |
| Completed |
NCT02532608 -
Infra-slow Oscillations During Sleep
|
N/A | |
| Completed |
NCT01528462 -
Sleep Disorders Managed and Assessed Rapidly in Transient Ischemic Attack (TIA) and In Early Stroke
|
||
| Completed |
NCT00748098 -
Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance
|
Phase 3 |